Statement of Stockholders' Equity (Unaudited) - USD ($)	Series A Warrants [Member] Common Stock [Member]	Series A Warrants [Member] Additional Paid-in Capital [Member]	Series A Warrants [Member]	Series B Warrants [Member] Common Stock [Member]	Series B Warrants [Member] Additional Paid-in Capital [Member]	Series B Warrants [Member]	Investment Banker [Member] Common Stock [Member]	Investment Banker [Member] Additional Paid-in Capital [Member]	Investment Banker [Member]	Investor Relations Consultant [Member] Common Stock [Member]	Investor Relations Consultant [Member] Additional Paid-in Capital [Member]	Investor Relations Consultant [Member]	GLG Pharma, LLC. [Member] Common Stock [Member]	GLG Pharma, LLC. [Member]	Former CEO [Member] Common Stock [Member]	Former CEO [Member] Additional Paid-in Capital [Member]	Former CEO [Member]	The 2016 Registered Direct Offering [Member] Common Stock [Member]	The 2016 Registered Direct Offering [Member] Additional Paid-in Capital [Member]	The 2016 Registered Direct Offering [Member]	Over-Allotment Option [Member] Common Stock [Member]	Over-Allotment Option [Member] Additional Paid-in Capital [Member]	Over-Allotment Option [Member]	Consulting Agreement [Member] Preferred Stock [Member]	Consulting Agreement [Member] Common Stock [Member]	Consulting Agreement [Member] Additional Paid-in Capital [Member]	Consulting Agreement [Member] Retained Earnings [Member]	Consulting Agreement [Member] AOCI Attributable to Parent [Member]	Consulting Agreement [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Vesting Expense																																$ 165,271			$ 165,271
Shares issued for preferred stock conversion into common stock per the break-up of the Unit from the 2015 public offering (in shares)																															66,396
Balance (in shares) at Dec. 31, 2015																															208,259
Balance at Dec. 31, 2015																														$ 18,950	$ 2,080	44,584,118	$ (40,492,437)		4,112,711
Shares issued for two options exercised at $65.75 per share (in shares)																															1,312
Shares issued for two options exercised at $65.75 per share																															$ 13	86,240			86,253
Shares issued for preferred stock conversion into common stock per the break-up of the Unit from the 2015 public offering																														(18,158)	$ 664	17,494			0
Shares issued for cashless warrant exercises (in shares)	2,318,663			628,237
Shares issued for cashless warrant exercises	$ 23,187	$ 556,479	$ 579,666	$ 6,282	$ 150,777	$ 157,059
Shares issued for services (in shares)							135,995
Shares issued for services							$ 1,360	$ 508,620	$ 509,980
Unrealized gain from marketable securities																																		$ 1,501	1,501
Shares Issued (in shares)										26,000			400,000		20,000			756,999
Shares Issued										$ 260	$ 116,740	$ 117,000	$ 4,000	$ 4,000	$ 200	$ 90,151	$ 90,351	$ 7,570	$ 1,618,335	$ 1,625,905
Corrections due to rounding for reverse split and DTCC increase (in shares)																															2,567
Corrections due to rounding for reverse split and DTCC increase																															$ 28	(29)			(1)
Net loss																																	(6,526,014)		(6,526,014)
Balance at Dec. 31, 2016																														792	$ 45,644	47,894,196	(47,018,451)	1,501	923,682
Balance (in shares) at Dec. 31, 2016																															4,564,428
Reverse shares issued for escrow with GLG Pharma pursuant to termination agreement (in shares)																															(400,000)
Vesting Expense																																2,131,821			2,131,821
Reverse shares issued for escrow with GLG Pharma pursuant to termination agreement																															$ (4,000)				(4,000)
Shares issued for services (in shares)																									100,000
Shares issued for services																									$ 1,000	$ 219,000			$ 220,000
Unrealized gain from marketable securities																																		$ (1,501)
Shares Issued (in shares)																					175,000										1,750,000
Shares Issued																					$ 1,750	$ 392,000	$ 393,750								$ 17,500	3,403,688			3,421,188
Net loss																																	(3,885,517)		(3,885,517)
Balance at Jun. 30, 2017																														$ 792	$ 61,894	$ 54,040,705	$ (50,903,968)		$ 3,199,423
Balance (in shares) at Jun. 30, 2017																															6,189,428